Asia Pacific Aspiration & Biopsy Needles Market Size, Share & Industry Trends Analysis Report By Product Type, By Procedure, By Image-guided Type, By End User, By Application, By Tumor/ Cancer Applications Type, By Country and Growth Forecast, 2022-2028

The Asia Pacific Aspiration & Biopsy Needles Market is expected to witness market growth of 7.1% CAGR during the forecast period (2022-2028).

In the near future, demand for aspiration and biopsy needles is projected to be fuelled by the launch of technologically enhanced devices that offer high precision and safety while giving a correct diagnosis. Due to increased demand from healthcare providers, manufacturers have adopted more stringent standards on product quality, sterility assurance, and manufacturing methods. In hospitals, clinics, and other end-users across the Asia Pacific region, the development of minimally invasive techniques for diagnosis, treatment, and prognosis has fuelled the demand for aspiration and biopsy needles. There is growing senior population is expected to improve medical practitioner adoption rates.

Additionally, the adoption of biopsy equipment is fuelled by an increase in the incidence of cancers such as breast, prostate, and lung, as well as rapid technological improvements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies. Furthermore, as people become more aware of how to diagnose chronic diseases, the demand for integrated biopsy technologies like a stereotactic-guided biopsy is growing.

The large population in countries like India and China, the rising incidence and awareness of cancer, improvement in the healthcare infrastructure, rising healthcare expenditure, increasing per capita income, government initiatives, and the increasing focus of key Market players on emerging APAC countries are all factors to contribute to the regional aspiration & biopsy needles Market in the coming years..

This increase is attributable to an increase in the number of chronic diseases that are spreading as a result of an unhealthy and sedentary lifestyle. Aspiration and biopsy needles are used to treat diseases like cancer in a variety of ways, from diagnostics to therapeutic applications. Rising investments in cancer diagnosis and screening programs, as well as research and development, are examples of other variables. Surgeons, diagnostic centers, and hospitals utilize these needles for biopsies such as bone needle biopsy and thyroid biopsy needle size. Aspiration and biopsy needles are in more demand as a result of this. Cases of lung cancer are on the rise in the region due to the poor air quality and prevalence of smoking. The growing income also allows the people in this region to seek treatment.

The China Market dominated the Asia Pacific Aspiration & Biopsy Needles Market by Country in 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $106.2 million by 2028. The Japan Market is poised to grow at a CAGR of 6.4% during (2022-2028). Additionally, The India Market is expected to witness a CAGR of 7.7% during (2022-2028).

Based on Product Type, the Market is segmented into Biopsy Needles and Aspiration Needles. Based on Procedure, the Market is segmented into Image-guided and Nonimage-guided. Based on Image-guided Type, the Market is segmented into Ultrasound-guided, CT-guided, MRI-guided, Stereotactic, and Others. Based on End User, the Market is segmented into Hospitals & surgical centers, Diagnostic Clinics & pathology laboratories, Ambulatory care centers, Research & Academic Institutes. Based on Application, the Market is segmented into Tumor/ Cancer Applications, Wound Applications, and Others. Based on Tumor/ Cancer Applications Type, the Market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Bone & Bone Marrow Cancer, and Others. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Johnson & Johnson, Merit Medical Systems, Inc., Cardinal Health, Inc., Becton, Dickinson and Company, ConMed Corporation, Olympus Corporation, Argon Medical Devices, Inc., and Cook Medical, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Product Type

• Biopsy Needles
• Aspiration Needles

By Procedure

• Image-guided
  • Ultrasound-guided
  • CT-guided
  • MRI-guided
  • Stereotactic
  • Others
• Nonimage-guided

By End User

• Hospitals & surgical centers
• Diagnostic Clinics & pathology laboratories
• Ambulatory care centers
• Research & Academic Institutes

By Application

• Tumor/ Cancer Applications
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Bone & Bone Marrow Cancer
  • Others
• Wound Applications
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Boston Scientific Corporation
• Medtronic PLC
• Johnson & Johnson
• Merit Medical Systems, Inc.
• Cardinal Health, Inc.
• Becton, Dickinson and Company
• ConMed Corporation
• Olympus Corporation
• Argon Medical Devices, Inc.
• Cook Medical, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free